Health Technology Assessment and Market Access
The fourth Innovation Day Taguspark is scheduled for October 24 and is dedicated to the theme “Health Technology Assessment and Market Access”.
With the presence of experts in the field, this event focuses on three points:
- The role of Health Technology Assessment (HTA) in Access to Therapeutic Innovation
- Access to Therapeutic Innovation in Portugal: main challenges
- Market access in Europe: Similarities and contrasts between EU countries
With free admission, but subject to reservation, the Innovation Day includes a series of meetings/debates that, from the Panoramic Restaurant (floor 4 of the Taguspark Central Nucleus), aim to explore the technological scenario in the startup areas of the Taguspark Incubator.
Program
17H0 – 19H00
Welcome
Eduardo Baptista Correia, CEO Taguspark
Speakers
Francisco Batel Marques, Co-Founder Clevidence
Telma Costa, Scientific Affairs & Pharma Business Development Director
Alicia de Castro Aguirre, Portugal Country Manager Eli Lilly
Debate
“Health Technology Assessment and Market Access”
Questions & Answers
Networking & Cocktail
